Click to view the full infographic
2018 was a remarkable year for industry. The FDA approved 59 new molecular entities (NMEs), breaking the 1996 record of 50 approvals, while the EMA suggested 84 new medicines for EU approval, 42 of these being new active substances (NASs), compared with 35 NAS.
This infographic provides an overview of the NMEs/NASs that were approved/recommended for approval by both associations in 2018.
